Procter & Gamble Health Limited — Updates, 29-05-2025: Press Release

Procter & Gamble Health reported quarterly sales up 23% at ₹304 Cr and PAT rising 31% to ₹61 Cr, fueled by strong branding and better supply chain efficiency. Nine-month sales increased 8% to ₹918 Cr, with PAT up 27% to ₹234 Cr (14% excluding one-offs). The company is focusing on product portfolio rationalization and operational agility to maintain balanced growth. A final dividend of ₹45 per share is proposed, bringing total payouts to ₹125 per share.